multiple lipoprotein-type hyperlipidemia

多種リポタンパク質型高脂血症、多種リポ蛋白型高脂血症

関

familial combined hyperlipidemia

WordNet

1. write by means of a keyboard with types; "type the acceptance letter, please" (同)typewrite
2. a small metal block bearing a raised character on one end; produces a printed character when inked and pressed on paper; "he dropped a case of type, so they made him pick them up"
3. (biology) the taxonomic group whose characteristics are used to define the next higher taxon
4. a subdivision of a particular kind of thing; "what type of sculpture do you prefer?"
5. all of the tokens of the same symbol; "the word `element contains five different types of character"
6. printed characters; "small type is hard to read"
7. identify as belonging to a certain type; "Such people can practically be typed" (同)typecast
8. having or involving or consisting of more than one part or entity or individual; "multiple birth"; "multiple ownership"; "made multiple copies of the speech"; "his multiple achievements in public life"; "her multiple personalities"; "a pineapple is a multiple fruit"
9. the product of a quantity by an integer; "36 is a multiple of 9"
10. a conjugated protein having a lipid component; the principal means for transporting lipids in the blood
11. writing done with a typewriter (同)typewriting

PrepTutorEJDIC

1. 〈C〉(…の)『型』,タイプ,類型,種類(kind)《+of+名》 / 〈C〉(その種類の特質を最もよく表している)『典型』,手本,模範《+of+名》 / 〈U〉《集合的に》活字;〈C〉(1個の)活字 / 〈U〉(印刷された)字体,活字 / 〈C〉(貨幣・メダルなどの)模様,図柄 / 〈C〉血液型(blood group) / …‘を'タイプに打つ / (…として)…‘を'分類する《+名+as+名(doing)》 / …‘の'型を決める / タイプライターを打つ
2. 多数の部分(要素)から成る,複合の,複式の / 倍数

UpToDate Contents

全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.

• 1. 高トリグリセリド血症患者に対するアプローチ approach to the patient with hypertriglyceridemia
• 2. リポ蛋白の分類、代謝、およびアテローム性動脈硬化症における役割 lipoprotein classification metabolism and role in atherosclerosis
• 3. 二次予防における脂質（高コレステロール血症を含む）の治療 treatment of lipids including hypercholesterolemia in secondary prevention
• 4. 血中脂質およびリポ蛋白の測定 measurement of blood lipids and lipoproteins
• 5. LDLコレステロール代謝の遺伝性疾患 inherited disorders of ldl cholesterol metabolism

English Journal

• Contribution of mutations in low density lipoprotein receptor (LDLR) and lipoprotein lipase (LPL) genes to familial combined hyperlipidemia (FCHL): A reappraisal by using a resequencing approach.

• Minicocci I1, Prisco C1, Montali A1, Di Costanzo A1, Ceci F2, Pigna G1, Arca M3.
• Atherosclerosis.Atherosclerosis.2015 Oct;242(2):618-24. doi: 10.1016/j.atherosclerosis.2015.06.036. Epub 2015 Jun 18.
• BACKGROUND: Defective low-density lipoprotein receptor (LDLR) and lipoprotein lipase (LPL) alleles have been implicated in familial combined hyperlipidemia (FCHL). However, their contribution might have been influenced by diagnostic criteria. This study was aimed to reassess the frequency of rare an
• PMID 26342331

• Infusion of angiotensin II increases fibrinolysis in healthy individuals but not in patients with familial combined hyperlipidemia.

• Ekholm M1, Kahan T, Jörneskog G, Bröijersén A, Wallén NH.
• Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.Blood Coagul Fibrinolysis.2015 Sep 1. [Epub ahead of print]
• Impaired fibrinolysis is related to insulin resistance, also a characteristic feature of familial combined hyperlipidemia (FCHL). The renin-angiotensin (Ang) system is upregulated with insulin resistance, and there is crosstalk between Ang II and insulin-signalling pathways. We studied the fibrinoly
• PMID 26340459

• Decreased plasma endogenous soluble RAGE, and enhanced adipokine secretion, oxidative stress and platelet/coagulative activation identify non-alcoholic fatty liver disease among patients with familial combined hyperlipidemia and/or metabolic syndrome.

• Santilli F1, Blardi P2, Scapellato C3, Bocchia M4, Guazzi G5, Terzuoli L3, Tabucchi A3, Silvietti A3, Lucani B4, Gioffrè WR6, Scarpini F7, Fazio F1, Davì G1, Puccetti L8.
• Vascular pharmacology.Vascul Pharmacol.2015 Sep;72:16-24. doi: 10.1016/j.vph.2015.04.004. Epub 2015 Jun 25.
• OBJECTIVE: In patients with familial combined hyperlipidemia (FCHL), without metabolic syndrome (MS), occurrence of non-alcoholic fatty liver disease (NAFLD) is related to a specific pro-inflammatory profile, influenced by genetic traits, involved in oxidative stress and adipokine secretion. Among F
• PMID 26117210

Related Links

• Hyperlipidemia - National Library of Medicine - PubMed Health

Summaries for consumers Omega‐3 polyunsaturated fatty acids (PUFA) for type 2 diabetes mellitus People with type 2 diabetes are known to be at increased risk of cardiovascular disease (such as heart attack or stroke). Type 2 ...

• Familial combined hyperlipidemia | University of Maryland ...

Causes Familial combined hyperlipidemia is the most common genetic disorder that increases blood fats. It can cause early heart attacks. However, researchers have not yet found which specific genes cause it. Diabetes

---

★リンクテーブル★

リンク元	「多種リポ蛋白型高脂血症」「多種リポタンパク質型高脂血症」
拡張検索	「familial multiple lipoprotein-type hyperlipidemia」
関連記事	「type」「multiple」「typed」「typing」「lipoprotein」

「多種リポ蛋白型高脂血症」

　　[★]

英

multiple lipoprotein-type hyperlipidemia

関

家族性複合型高脂血症、多種リ・タンパク質型高脂血症

「多種リポタンパク質型高脂血症」

　　[★]

英

multiple lipoprotein-type hyperlipidemia

関

多種リポ蛋白型高脂血症

「familial multiple lipoprotein-type hyperlipidemia」

　　[★] 家族性高リポ蛋白血症IIb型

「type」

　　[★]

• n.

• 型、タイプ、(生物)タイプ標本

(windows)ファイル内容表示(linux -> cat])

ex. type report_20111118.jp.htm | php a.php > report_20111118.jp.jp.jp.html

関

form、mode、pattern、type specimen、typed

　 　 　 　 　 　 　 　

「multiple」

　　[★]

• n.

• 倍数

• adj.

関

multifocality、multiplex、plural

　 　 　

「typed」

　　[★]

• adj.

• 型の

関

form、mode、pattern、type

「typing」

　　[★]

• n.

• タイプで打つこと、タイピング。分類

　

「lipoprotein」

　　[★] リポ蛋白 lipoprotein